45 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
with milestones to be established by the Board. Mr. Buckler was entitled to receive a retention bonus where the Company will pay $45,000 on the earlier … and enforce compliance with the Code;
(ll) establish procedures for: i) the receipt, retention and treatment of complaints regarding accounting
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
9 Aug 23
Statement of Executive Compensation
7:41pm
was entitled to receive a retention bonus where the Company will pay $45,000 on the earlier of April 30, 2016 or 30 days after the Company completed
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
by the Board. Mr. Buckler was entitled to receive a retention bonus where the Company will pay $45,000 on the earlier of April 30, 2016 or 30 days after
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
7 Jul 22
Statement of Executive Compensation
1:43pm
a retention bonus where the Company will pay $45,000 on the earlier of April 30, 2016 or 30 days after the Company completes an equity financing
6-K
EX-99.1
gtc7k3inqc7u4vd4lb
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.1
zn9mpfgk
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
20-F/A
twk98uol
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.4
dlcq r2mwg
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
mn8tc8pd4gdorm lfn7
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
w81j3kt
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
p5ddvgsug7dqvjf
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
e3znq6
22 Jan 19
Current report (foreign)
4:43pm